Evaluating the effect of vitamin D3 supplementation on anxiety, depression, sleep quality, physical morbidity and oxidative stress in university students

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201703076026N5

Enrollment

Registered

2017-03-10

Start date

2017-05-01

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: Depression. Condition 3: Sleep disorder. Anxiety disorder, unspecified Depressive episode, unspecified Sleep disorders

Interventions

Intervention 1: Intervention: Two vitamin D3 pearls (50000 IU) at baseline and after 1 month. Intervention 2: Control: Two placebo Pearls at baseline and after on month.

Treatment - Drugs

Placebo

Intervention: Two vitamin D3 pearls (50000 IU) at baseline and after 1 month

Control: Two placebo Pearls at baseline and after on month

Eligibility

Sex/Gender

All

Age

20 Years to 25 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: University student in the 20-25 age range; Having an underlying disease, Exclusion: Concurrent other vitamin D supplements use during the study period

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Mental disorder. Timepoint: At baseline and after 2 months. Method of measurement: Questionnaires.;Oxidative stress. Timepoint: At baseline and after 2 months. Method of measurement: Oxidative stress biomarkers.	—

Secondary

Measure	Time frame
Physical morbidity. Timepoint: At baseline and after 2 months. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Dabaghzadeh

Kerman University of Medical Sciences

fatemeh_dabaghzadeh@yahoo.com+98 34 3132 5212

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026